Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Ruijin Hospital

15 clinical trials · 15 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Ruijin Hospital

RECRUITINGPhase 2NCT06269211

Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1...

The study is a prospective, open label, multicenter, single arm Phase II clinical trial, aiming to explore the use of neoadjuvant Toripalimab for clinically stage II-IIIB NSCLC...

Sponsor: Ruijin HospitalEnrolling: 292 locations
Carcinoma, Non-Small-Cell Lung
RECRUITINGPhase 2NCT06114225

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body...

The aim of this study is to evaluate the efficacy and safety of pre-operative concurrent Stereotactic Body Radiotherapy (SBRT) and and programmed cell death protein-1 (PD-1)...

Sponsor: Ruijin HospitalEnrolling: 431 location
Osteosarcoma
RECRUITINGNCT06966440

Adjuvant Pancreatic Therapy Guided by MRD

Pancreatic adenocarcinoma (PAAD) is a leading cause of cancer-related deaths worldwide. Although surgical resection can be curative, the 5-year overall survival (OS) rate after...

Sponsor: Ruijin HospitalEnrolling: 8561 location
Pancreatic Adenocarcinoma Resectable
RECRUITINGPhase 2NCT06803693

Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

The purpose of this study is to compare the efficacy and safety of genotype-guided targeted agents in combination with polatuzumab vedotin plus rituximab, cyclophosphamide,...

Sponsor: Ruijin HospitalEnrolling: 1521 location
Diffuse Large B-Cell Lymphoma
RECRUITINGPhase 1NCT07072169

A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin...

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, as well as preliminary efficacy of mRNA encoding CD19/CD3 T cell engager...

Sponsor: Ruijin HospitalEnrolling: 561 location
B-cell Non-Hodgkin Lymphoma
RECRUITINGPhase 2NCT06519591

Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the...

In this phase 2 study, we combined Cadonilimab, LM-302, and S-1 combined with intraperitoneal infusion of paclitaxel as regimen to treat gastric cancer patients with peritoneal...

Sponsor: Ruijin HospitalEnrolling: 401 location
Gastric Cancer Stage IVPeritoneal Metastases
RECRUITINGPhase 3NCT06339060

An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).

Patients with locally advanced esophageal squamous cell carcinoma will randomly assigned to receive neoadjuvant chemo-radiotherapy combined with immunotherapy post organ...

Sponsor: Ruijin HospitalEnrolling: 3561 location
Esophageal Cancer
RECRUITINGPhase 2NCT06122493

Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma

This study aims to investigate a comprehensive therapeutic approach for patients with unresectable esophageal squamous cell carcinoma, clinically staged as Tany, N3, M0, and who...

Sponsor: Ruijin HospitalEnrolling: 481 location
Esophageal Squamous Cell Carcinoma
RECRUITINGNCT05597410

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes...

Sponsor: Ruijin HospitalEnrolling: 34181 location
Alzheimer DiseaseDementiaNeurodegenerative Diseases+2
RECRUITINGNCT07353463

Shanghai Clinical Cohort - Parkinson's Disease (Reserve)

The goal of this observational cohort studyis to establish a high-quality clinical cohort of Parkinson's disease (PD) and multiple system atrophy (MSA) patients in Shanghai, in...

Sponsor: Ruijin HospitalEnrolling: 7001 location
Parkinson's Disease (PD)Multiple System Atrophy
RECRUITINGNCT06796725

Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG

Using magnetoencephalography to locate and regulate targets in migraine patients, repeating transcranial magnetic stimulation to physically regulate targets, and evaluating the...

Sponsor: Ruijin HospitalEnrolling: 601 location
Migraine Disorders, BrainrTMS Stimulation
RECRUITINGNCT06829134

Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in...

The primary objective of this study is to evaluate the efficacy and safety of laparoscopic renal artery nerve blockade surgery in patients with retroperitoneal diseases...

Sponsor: Ruijin HospitalEnrolling: 2461 location
HypertensionRetroperitoneal Disease
RECRUITINGNCT06802016

A Study of Chinese Congenital Bicuspid Aortic Valve

Pervious studies indicated that the prevalence of bicuspid aortic valve(BAV) might be higher in China. There is a familial predisposition to the development of BAV. The study...

Sponsor: Ruijin HospitalEnrolling: 5001 location
Bicuspid Aortic Valve (BAV)
RECRUITINGPhase 1NCT06992661

A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With...

This Phase 1 clinical trial investigates the pharmacokinetics and safety profile of single-dose inhaled RJ026 in healthy volunteers and patients with interstitial lung disease...

Sponsor: Ruijin HospitalEnrolling: 841 location
Interstitial Lung Disease (ILD)Healthy Volunteers
RECRUITINGNCT05870969

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese...

The goal of this study is to evaluate whether the standardized liver cancer risk stratification management can effectively improve the early diagnosis rate of liver cancer in the...

Sponsor: Ruijin HospitalEnrolling: 200001 location
Carcinoma, HepatocellularHepatitis C, ChronicHepatitis B, Chronic+2